Back
PROCEPT BioRobotics Corp. 10K Form
Sell
44
PRCT
PROCEPT BioRobotics Corp.
Last Price:
$35.44
Seasonality Move:
-13.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRCT News And Ratings
See the #1 stock for the next 7 days that we like better than PRCT
PRCT Financial Statistics
Sales & Book Value
| Annual Sales: | $224.5M |
|---|---|
| Cash Flow: | $-9.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.81 |
| Price / Book: | 4.88 |
Profitability
| EPS (TTM): | -1.53790 |
|---|---|
| Net Income (TTM): | $-84.6M |
| Gross Margin: | $137.1M |
| Return on Equity: | -23.51% |
| Return on Assets: | -17.25% |
PROCEPT BioRobotics Corp. Earnings Forecast
Key PROCEPT BioRobotics Corp. Financial Ratios
-
The Gross Profit Margin over the past 6 years for PRCT is 61.07%.
-
The Selling, General & Administrative Expenses for PRCT have been equal to 76.35% of Gross Profit Margin.
-
The Research & Development expenses have been 27.75% of Revenue.
-
The Net Earning history of PRCT is -40.72% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 1 years.
PROCEPT BioRobotics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | PRCT |
| Website: | procept-biorobotics.com |
Debt
| Debt-to-Equity Ratio: | 0.21 |
|---|---|
| Current Ratio: | 8.43 |
| Quick Ratio: | 7.07 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PRCT Technical Analysis vs Fundamental Analysis
Sell
44
PROCEPT BioRobotics Corp. (PRCT)
is a Sell
Is PROCEPT BioRobotics Corp. a Buy or a Sell?
-
PROCEPT BioRobotics Corp. stock is rated a SellThe current PROCEPT BioRobotics Corp. [PRCT] share price is $33.18. The Score for PRCT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.